Erratum: Crucial role of miR-433 in regulating cardiac fibrosis (Theranostics (2016) 6:12 (2068-2083) DOI: 10.7150/thno.15007);Crucial role of miR-433 in regulating cardiac fibrosis

Theranostics

Volumn 6, Issue 12, 2016, Pages 2068-2083

  Tao, Lichan ^a   Bei, Yihua ^b   Chen, Ping ^b   Lei, Zhiyong ^c   Fu, Siyi ^b   Zhang, Haifeng ^a   Xu, Jiahong ^d   Che, Lin ^d   Chen, Xiongwen ^e   Sluijter, Joost P G ^c   Das, Saumya ^f   Cretoiu, Dragos ^g,h   Xu, Bin ^b   Zhong, Jiuchang ⁱ   Xiao, Junjie ^b   Li, Xinli ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b SHANGHAI UNIVERSITY   (China)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^e TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

^g VICTOR BABES NATIONAL INSTITUTE OF PATHOLOGY   (Romania)

^h CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

ⁱ SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

AZIN1; Cardiac fibrosis; JNK1; MiR 433

Indexed keywords

ANGIOTENSIN II; JANUS KINASE 1; MICRORNA; MICRORNA 433; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; MIRN433 MICRORNA, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AZIN1 GENE; CARDIAC MUSCLE CELL; CARDIOMYOPATHY; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; GENE; GENE IDENTIFICATION; GENE TARGETING; HEART FIBROBLAST; HEART INFARCTION; HEART MUSCLE FIBROSIS; JNK1 GENE; MALE; MOUSE; MYOFIBROBLAST; NEWBORN; NONHUMAN; RAT; ANIMAL; C57BL MOUSE; CELL CULTURE; COMPLICATION; FIBROSIS; GENE EXPRESSION PROFILING; METABOLISM; MYOBLAST; PATHOLOGY; PHYSIOLOGY;

ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; FIBROSIS; GENE EXPRESSION PROFILING; MICE, INBRED C57BL; MICRORNAS; MYOBLASTS; MYOCARDIAL INFARCTION; RATS;

EID: 84995527936     PISSN: None     EISSN: 18387640     Source Type: Journal    
DOI: 10.7150/THNO.63330     Document Type: Erratum

References (40)

1. Thum T. Noncoding rnas and myocardial fibrosis. Nat Rev Cardioy. 2014;11: 655-63.
2. Leask A. Getting to the heart of the matter: New insights into cardiac fibrosis. Cir Res. 2015;116:1269-76.
3. Segura AM, Frazier OH, Buja LM. Fibrosis and heart failure. Heart Fail Rev. 2014; 19: 173-85.
4. Thannickal VJ, Zhou Y, Gaggar A, Duncan SR. Fibrosis: Ultimate and proximate causes. J Clin Invest. 2014;124:4673-7.
5. Thum T, Lorenzen JM. Cardiac fibrosis revisited by microrna therapeutics. Circulation. 2012;126: 800-2.
6. McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, et al. Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med. 2014; 371:993-1004.
7. Olson EN. Micrornas as therapeutic targets and biomarkers of cardiovascular disease. Sci Transl Med. 2014;6:239ps3.
8. Quiat D, Olson EN. Micrornas in cardiovascular disease: From pathogenesis to prevention and treatment. J Clin Invest. 2013;123:11-8.
9. Mendell JT, Olson EN. Micrornas in stress signaling and human disease. Cell. 2012; 148:1172-87.
10. Piccoli MT, Gupta SK, Thum T. Noncoding rnas as regulators of cardiomyocyte proliferation and death. J Mol Cell Cardiol. 2015; 89:59-67.
11. Tao H, Yang JJ, Shi KH. Non-coding rnas as direct and indirect modulators of epigenetic mechanism regulation of cardiac fibrosis. Expert Opin Ther Targets. 2015; 19: 707-16.
12. Kumarswamy R, Thum T. Non-coding rnas in cardiac remodeling and heart failure. Cir Res. 2013;113:676-89.
13. Bernardo BC, Gao XM, Winbanks CE, Boey EJ, Tham YK, Kiriazis H, et al. Therapeutic inhibition of the mir-34 family attenuates pathological cardiac remodeling and improves heart function. Proc Natl Acad Sci U S A. 2012;109:17615-20.
14. Boon RA, Iekushi K, Lechner S, Seeger T, Fischer A, Heydt S, et al. Microrna-34a regulates cardiac ageing and function. Nature. 2013;495:107-10.
15. Jazbutyte V, Fiedler J, Kneitz S, Galuppo P, Just A, Holzmann A, et al. Microrna-22 increases senescence and activates cardiac fibroblasts in the aging heart. Age (Dordr). 2013;35:747-62.
16. Thum T, Gross C, Fiedler J, Fischer T, Kissler S, Bussen M, et al. Microrna-21 contributes to myocardial disease by stimulating map kinase signalling in fibroblasts. Nature. 2008;456:980-4.
17. Wei C, Kim IK, Kumar S, Jayasinghe S, Hong N, Castoldi G, et al. Nf-kappab mediated mir-26a regulation in cardiac fibrosis. J Cell Physiol. 2013;228:1433-42.
18. Zhang Y, Huang XR, Wei LH, Chung AC, Yu CM, Lan HY. Mir-29b as a therapeutic agent for angiotensin ii-induced cardiac fibrosis by targeting tgf-beta/smad3 signaling. Mol Ther. 2014;22:974-85.
19. Wang J, Huang W, Xu R, Nie Y, Cao X, Meng J, et al. Microrna-24 regulates cardiac fibrosis after myocardial infarction. J Cell Mol Med. 2012;16:2150-60.
20. Tijsen AJ, van der Made I, van den Hoogenhof MM, Wijnen WJ, van Deel ED, de Groot NE, et al. The microrna-15 family inhibits the tgfbeta-pathway in the heart. Cardiovasc Res. 2014;104: 61-71.
21. Li R, Chung AC, Dong Y, Yang W, Zhong X, Lan HY. The microrna mir-433 promotes renal fibrosis by amplifying the tgf-beta/smad3-azin1 pathway. Kidney Int 2013; 84: 1129-44.
22. Espinosa-Diez C, Fierro-Fernández M, Sánchez-Gómez F, Rodríguez-Pascual F, Alique M, Ruiz-Ortega M, et al. Targeting of gamma-glutamyl-cysteine ligase by mir-433 reduces glutathione biosynthesis and promotes tgf-beta-dependent fibrogenesis. Antioxid Redox Signal. 2015;23:1092-105.
23. Wahlquist C, Jeong D, Rojas-Muñoz A, Kho C, Lee A, Mitsuyama S, et al. Inhibition of miR-25 improves cardiac contractility in the failing heart. Nature. 2014;508:531-5.
24. Aoyama Y, Kobayashi K, Morishita Y, Maeda K, Murohara T. Wnt11 gene therapy with adeno-associated virus 9 improves the survival of mice with myocarditis induced by coxsackievirus B3 through the suppression of the inflammatory reaction. J Mol Cell Cardiol. 2015;84:45-51.
25. Zincarelli C, Soltys S, Rengo G, Rabinowitz JE. Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection. Mol Ther. 2008; 16:1073-80.
26. Karakikes I, Chaanine AH, Kang S, Mukete BN, Jeong D, Zhang S, et al. Therapeutic cardiac-targeted delivery of miR-1 reverses pressure overload-induced cardiac hypertrophy and attenuates pathological remodeling. J Am Heart Assoc. 2013;2:e000078.
27. Wang H, Chiu M, Xie Z, Chiu M, Liu Z, Chen P, et al. Synthetic microRNA cassette dosing: pharmacokinetics, tissue distribution and bioactivity. Mol Pharm 2012; 9: 1638-44.
28. Goldsmith EC, Bradshaw AD, Spinale FG. Cellular mechanisms of tissue fibrosis. 2. Contributory pathways leading to myocardial fibrosis: Moving beyond collagen expression. Am J Physiol Cell Physiol. 2013;304:C393-402.
29. Weber KT, Sun Y, Bhattacharya SK, Ahokas RA, Gerling IC. Myofibroblast-mediated mechanisms of pathological remodelling of the heart. Nat Rev Cardioy. 2013;10:15-26.
30. Peng T, Zhang T, Lu X, Feng Q. Jnk1/c-fos inhibits cardiomyocyte tnf-alpha expression via a negative crosstalk with erk and p38 mapk in endotoxaemia. Cardiovasc Res. 2009;81:733-41.
31. Rose BA, Force T, Wang Y. Mitogen-activated protein kinase signaling in the heart: Angels versus demons in a heart-breaking tale. Physiol Rev. 2010;90: 1507-46.
32. Melman YF, Shah R, Das S. Micrornas in heart failure: Is the picture becoming less mirky? Cir Heart Fail. 2014;7:203-14.
33. van Rooij E, Olson EN. Microrna therapeutics for cardiovascular disease: Opportunities and obstacles. Nat Rev Drug Discov. 2012;11:860-72.
34. Guo LH, Li H, Wang F, Yu J, He JS. The tumor suppressor roles of mir-433 and mir-127 in gastric cancer. Int J Mol Sci. 2013;14:14171-84.
35. Yang Z, Tsuchiya H, Zhang Y, Hartnett ME, Wang L. Microrna-433 inhibits liver cancer cell migration by repressing the protein expression and function of camp response element-binding protein. J Biol Chem. 2013;288:28893-9.
36. Tao L, Shen S, Fu S, Fang H, Wang X, Das S, et al. Traditional chinese medication qiliqiangxin attenuates cardiac remodeling after acute myocardial infarction in mice. Sci Rep. 2015;5:8374.
37. Weiner-Gorzel K, Dempsey E, Milewska M, McGoldrick A, Toh V, Walsh A, et al. Overexpression of the microrna mir-433 promotes resistance to paclitaxel through the induction of cellular senescence in ovarian cancer cells. Cancer Med. 2015;4:745-58.
38. Grotendorst GR, Rahmanie H, Duncan MR. Combinatorial signaling pathways determine fibroblast proliferation and myofibroblast differentiation. FASEB J. 2004;18: 469-79.
39. Wang Y. Mitogen-activated protein kinases in heart development and diseases. Circulation. 2007;116:1413-23.
40. Fan Z, Guan J. Antifibrotic therapies to control cardiac fibrosis. Biomater Res. 2016;20:13.